How do I calculate the fractional excretion of potassium (FEK) in a patient with persistent hypokalemia and a low urine potassium‑to‑creatinine ratio?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Calculate Fractional Excretion of Potassium (FEK)

The fractional excretion of potassium (FEK) is calculated using the formula: FEK (%) = (Urine K+ × Serum Creatinine) / (Serum K+ × Urine Creatinine) × 100.

The Formula and Required Values

To calculate FEK, you need four laboratory values from simultaneous blood and spot urine samples:

  • Urine potassium (UK+) in mEq/L or mmol/L
  • Serum potassium (SK+) in mEq/L or mmol/L
  • Urine creatinine (UCr) in mg/dL or mmol/L
  • Serum creatinine (SCr) in mg/dL or mmol/L

FEK (%) = (UK+ / SK+) / (UCr / SCr) × 100

Or equivalently: FEK (%) = (UK+ × SCr) / (SK+ × UCr) × 100

Interpretation in Hypokalemia

In patients with persistent hypokalemia, an FEK >9-10% indicates inappropriate renal potassium wasting, while FEK <6-7% suggests extrarenal losses 1, 2.

Specific Cutoff Values:

  • FEK <2.8-6.4%: Suggests hypokalemia from extrarenal losses (GI losses, inadequate intake, transcellular shifts) 1
  • FEK >9.3%: Indicates renal potassium wasting with 80.6% sensitivity and 85.7% specificity 2
  • FEK 9.5-24%: Strongly suggests renal tubular disorders, diuretic use, or mineralocorticoid excess as the cause 1

Clinical Context and Pitfalls

Important Considerations:

Recent diuretic use can falsely elevate FEK, making interpretation difficult. The test is most reliable when obtained before initiating potassium supplementation or after discontinuing diuretics for at least 24-48 hours.

In normal subjects, mean FEK is approximately 8% (range 4-16%) 1. FEK correlates positively with serum potassium levels (r = 0.74) and inversely with serum creatinine 1.

Alternative Markers:

If you cannot calculate FEK immediately, the urine potassium-to-creatinine ratio (UK/UCr) from a spot urine sample provides similar diagnostic information and correlates strongly with FEK (r = 0.831) 2. A UK/UCr ratio can be rapidly obtained and interpreted alongside FEK.

Practical Application Algorithm

  1. Obtain simultaneous samples: Collect spot urine and serum samples at the same time, ideally before treatment initiation
  2. Calculate FEK using the formula above
  3. Interpret based on clinical context:
    • FEK <7% + low urine K/Cr ratio → Extrarenal losses (vomiting, diarrhea, poor intake)
    • FEK >9-10% + normal/high urine K/Cr ratio → Renal wasting (diuretics, tubular disorders, hyperaldosteronism)
  4. Consider confounders: Recent diuretics, acid-base status, and volume status all affect interpretation

In patients receiving potassium supplementation, FEK remains the most reliable spot urine parameter for distinguishing renal from extrarenal losses 2, making it superior to isolated urine potassium measurements or the transtubular potassium gradient (TTKG) in this setting.

References

Related Questions

Is a single spot urine potassium-to-creatinine ratio sufficient to determine renal potassium loss?
In a patient with persistent hypokalemia and a low urine potassium-to-creatinine ratio (approximately 5), what is the next step in management?
In a patient with persistent hypokalemia, an elevated potassium‑to‑creatinine ratio, and a high fractional excretion of potassium, what is the next step in management?
What is the clinical significance of a fractional excretion of potassium (FEK) of 12.5% and how should it be managed?
What is the normal urine potassium concentration and how should high or low urine potassium values be interpreted in relation to serum potassium and clinical context?
What is the appropriate dosing regimen for eltrombopag in adult and pediatric patients with immune thrombocytopenia, including adjustments for hepatic impairment and aplastic anemia?
In a 55-year-old man with diabetes mellitus who has a moderately severe bilateral symmetric sensorimotor polyneuropathy of the lower extremities and a possible chronic right L5 radiculopathy, what is the appropriate management and medication regimen?
What are the indications for intervention, such as splenectomy, in patients with hypersplenism?
In a patient with acute alcoholic hepatitis and thrombocytopenia, how should the low platelet count be evaluated and managed?
What is the appropriate diagnostic workup and management for a patient with elevated cortisol levels and hyponatremia?
What is the recommended management for hypersplenism in thalassemia, including indications for splenectomy, pre‑operative vaccination, prophylactic antibiotics, and alternative therapies?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.